IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden
· Delayed Price · Currency is SEK 3.065
+0.040 (1.32%)
Aug 22, 2025, 5:29 PM CET
IRLAB Therapeutics AB Revenue
IRLAB Therapeutics AB had revenue of 19.53M SEK in the quarter ending June 30, 2025, a decrease of -54.34%. This brings the company's revenue in the last twelve months to 75.74M, up 82.14% year-over-year. In the year 2024, IRLAB Therapeutics AB had annual revenue of 94.63M with 1,566.57% growth.
Revenue (ttm)
75.74M
Revenue Growth
+82.14%
P/S Ratio
3.52
Revenue / Employee
2.52M
Employees
31
Market Cap
266.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94.63M | 88.95M | 1,566.57% |
| Dec 31, 2023 | 5.68M | -55.46M | -90.71% |
| Dec 31, 2022 | 61.14M | -146.65M | -70.58% |
| Dec 31, 2021 | 207.78M | 207.48M | 69,160.67% |
| Dec 31, 2020 | 300.00K | -72.00K | -19.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.31B |
| Getinge AB | 35.50B |
| Camurus AB | 2.27B |
| Medicover AB | 25.22B |
| Asker Healthcare Group AB | 15.88B |
| BioArctic AB | 1.52B |
| AddLife AB | 10.44B |